Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04291417 · ClinicalTrials.gov registry record
Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Baylor S&W
A clinical trial, sponsored by Beckman Coulter.
- Completed
- Registry status
- 1,700
- Enrollment target
NCT04291417 is a clinical trial that has completed, run by Beckman Coulter. The registered enrollment target is 1,700 participants.
The verdict
NCT04291417 has completed, sponsored by Beckman Coulter.
- COMPLETED
- Registry status
- 1,700 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that addition of the Monocyte Width Distribution (MDW) parameter to current standard of care improves a clinician's ability to recognize sepsis in the Emergency Department, resulting in earlier decision to administer antibiotics from time of ED presentation for sepsis patients (simulated primary endpoint), with concomitant reductions in length of stay and in-hospital mortality for those patients (secondary endpoints).
Interventions
- DIAGNOSTIC_TEST CBC-DIFF Monocyte Volume Width Distribution (MDW)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,700 participants |
| Start Date | 2019-11-20 |
| Est. Completion | 2020-06-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04291417
The ClinicalTrials.gov registry entry for NCT04291417 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,700 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beckman Coulter, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CBC-DIFF Monocyte Volume Width Distribution (MDW) is the first listed.
NCT04291417 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04291417 about?
NCT04291417 is a clinical study titled "Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Baylor S&W". The purpose of this study is to demonstrate that addition of the Monocyte Width Distribution (MDW) parameter to current standard of care improves a clinician's ability to recognize sepsis in the Emergency Department, resulting in earlier decision to administer antibiotics from time of ED presentatio...
What is the current status of trial NCT04291417?
This trial is currently completed. The enrollment target is 1,700 participants. The study started on 2019-11-20. Estimated completion is 2020-06-17.
What interventions are being tested in trial NCT04291417?
The interventions under investigation include: CBC-DIFF Monocyte Volume Width Distribution (MDW) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04291417?
This trial is sponsored by Beckman Coulter, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.